Patent · US Active

Anti-SIRPA antibodies and methods of use thereof

US11319373B2 · kind B2 · utility

1Cited by

10References

83Claims

0Family size

Assignee

Alector LLC

Inventors

Andrew Pincetic · New York, US
Wei-Hsien Ho · Belmont, US
Patricia Culp · Oakland, US
Arnon Rosenthal · Woodside, US

Key dates

Filing date	May 24, 2019
Grant date	May 3, 2022
Priority date	—
Expiry date	Feb 24, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, antibodies, antibody fragments, etc., that specifically bind a SIRPA polypeptide, e.g., a mammalian SIRPA or human SIRPA, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.